Search research articles
Contact Us
Filters
Showing results (171-180 of 184) with videos related to
Page
of 19
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
Anita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
Cancer
|
August 30, 2022
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
Michael Scordo, Gunjan L Shah, Peter A Adintori, et al.
Nature Reviews. Nephrology
|
December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
Amanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Older patients with myeloma derive similar benefit from autologous transplantation
Manish Sharma, Mei-Jie Zhang, Xiaobo Zhong, et al.
JAMA Oncology
|
April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial
Ola Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Nature Communications
|
July 19, 2020
Accelerated single cell seeding in relapsed multiple myeloma
Heather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 184) with videos related to
Sort By:
Page
of 19
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
Anita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
Cancer
|
August 30, 2022
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
Michael Scordo, Gunjan L Shah, Peter A Adintori, et al.
Nature Reviews. Nephrology
|
December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
Amanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Older patients with myeloma derive similar benefit from autologous transplantation
Manish Sharma, Mei-Jie Zhang, Xiaobo Zhong, et al.
JAMA Oncology
|
April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial
Ola Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Nature Communications
|
July 19, 2020
Accelerated single cell seeding in relapsed multiple myeloma
Heather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Page
of 19